SCINTOMICS Molecular, Applied Theranostics Technologies GmbH

Industry / private company

Location: Fürstenfeldbruck, Germany (DE)

Publications

(3)

Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy (2019) Lapa C, Lueckerath K, Kircher S, Haenscheid H, Grigoleit GU, Rosenwald A, Stolzenburg A, et al. Journal article [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory values (2017) Lapa C, Schreder M, Schirbel A, Samnick S, Kortuem KM, Herrmann K, Kropf S, et al. Journal article CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed multiple myeloma (2017) Lapa C, Herrmann K, Schirbel A, Haenscheid H, Luerckerath K, Schottelius M, Kircher M, et al. Journal article